SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-030448
Filing Date
2024-08-06
Accepted
2024-08-06 17:20:13
Documents
21
Period of Report
2024-08-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39405
2 ex99-1.htm EX-99.1 60755
3 ex99-1_001.jpg GRAPHIC 111140
4 ex99-1_002.jpg GRAPHIC 122058
5 ex99-1_003.jpg GRAPHIC 135374
6 ex99-1_004.jpg GRAPHIC 122910
7 ex99-1_005.jpg GRAPHIC 120969
8 ex99-1_006.jpg GRAPHIC 98342
9 ex99-1_007.jpg GRAPHIC 127509
  Complete submission text file 0001493152-24-030448.txt   1434485

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ntbl-20240806.xsd EX-101.SCH 3024
11 XBRL LABEL FILE ntbl-20240806_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE ntbl-20240806_pre.xml EX-101.PRE 22365
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3441
Mailing Address 320 HATCH DRIVE FOSTER CITY CA 94404
Business Address 320 HATCH DRIVE FOSTER CITY CA 94404 415-851-2410
Notable Labs, Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36581 | Film No.: 241180551
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)